Is methane a new therapeutic gas? by Wenwu Liu et al.
MEDICAL GAS 
RESEARCH
Liu et al. Medical Gas Research 2012, 2:25
http://www.medicalgasresearch.com/content/2/1/25COMMENTARY Open AccessIs methane a new therapeutic gas?
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Background: Methane is an attractive fuel. Biologically, methanogens in the colon can use carbon dioxide and
hydrogen to produce methane as a by-product. It was previously considered that methane is not utilized by
humans. However, in a recent study, results demonstrated that methane could exert anti-inflammatory effects in a
dog small intestinal ischemia-reperfusion model.
Point of view: Actually, the bioactivity of methane has been investigated in gastrointestinal diseases, but the exact
mechanism underlying the anti-inflammatory effects is required to be further elucidated. Methane can cross the
membrane and is easy to collect due to its abundance in natural gas. Although methane is flammable, saline rich
in methane can be prepared for clinical use. These seem to be good news in application of methane as a
therapeutic gas.
Conclusion: Several problems should be resolved before its wide application in clinical practice.
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In a recent study of Boros et al., methane was shown
to confer protective effect on the oxidative stress and
inflammation in ischemic and reperfusion induced intes-
tinal injury [1]. In the methane treated canines, Boros
et al. demonstrated that inhalation of 2.5% methane for
15 min significantly ameliorated the histological damage
to the intestinal mucosa and dramatically decreased the
myeloperoxidase, a marker for oxidative stress and neu-
trophilic infiltration. In the in vitro experiments, results
showed incubation with 2.5% methane at normal pres-
sure could inhibit the superoxide production in cultured
primary canine granulocytes following stimulation. They
also noted that 2.5% methane inhalation for 3 h had no
side effects on the blood gas chemistry and no influence
on the macrohemodynamics in unstressed rats.Characteristics and synthesis of methane
Methane is a chemical compound with the chemical for-
mula CH4. It was discovered and isolated by Alessandro
Volta between 1776 and 1778 when studying marsh gas* Correspondence: sunxjk@hotmail.com
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reproduction in any medium, provided the orfrom Lake Maggiore. Methane is the simplest alkane, the
main component of natural gas (about 87% by volume),
and probably the most abundant organic compound on
earth [2]. Thus, it has been an attractive fuel. In the
chemical industry, methane is converted to synthesis gas,
a mixture of carbon monoxide (CO) and hydrogen (H2),
by steam reforming. Methane is non-toxic; however, it is
extremely flammable and may form explosive mixtures
with air: it is flammable only over a narrow range of con-
centrations (5–15%) in air [3].
Methane can be synthesized in biological route and
industrial route. In the industrial route, methane is pro-
duced by hydrogenating carbon dioxide (CO2) through
the Sabatier process. However, the intentional production
of methane is relatively rare due to its abundance in
natural gas. In the biological route, methanogens in the
colon can use CO2 and H2 to produce methane as a by-
product [4]. Methane gas is produced by enteric bacteria
in 30–62% of humans [5] and some studies have focused
on the relationship between methane production and
intestinal diseases such as constipation predominant
irritable bowel syndrome (C-IBS), diverticulosis and colon
cancer [4,6,7]. In addition, Ghyczy et al. found that
the rat mitochondrial subfractions and endothelial cell
cultures under hypoxic conditions had methane gene-
ration, which represented an alternative approach to
methanogenesis [8].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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anaerobic fermentation in the gut [9]. It was previously
considered that methane is not utilized by humans (inert
or biologically inactive), so it is excreted either as flatus,
or it traverses the intestinal mucosa and is absorbed into
the systemic circulation and excreted unchanged through
the lungs. In a study, pulmonary methane excretion ran-
ged from undetectable to 0.66 ml/min, and 20% of total
methane produced was excreted via the lungs [10]. This
is the basis of lactulose breath test (LBT). Due to its ease
of administration and minimal invasiveness, breath tes-
ting has become a widely used tool in diagnosis of certain
gastrointestinal conditions and disorders of transit [6].
Biology of methane
In past decades, there has been extraordinary, rapid
growth in our knowledge on gaseous molecules, including
nitric oxide (NO), CO and hydrogen sulfide (H2S), which
have been known to play important roles in the biological
systems [11]. Actually, the bioactivity of methane is not a
novel phenomenon in medicine. Studies have shown that
methane can slow the intestinal transit by altering intes-
tinal neuromuscular function [5] and decrease peristaltic
velocity and increase contraction amplitude significantly
of guinea pig ileum [7].
The Occupational Safety Hazards Administration of
United States has regarded methane as a simple as-
phyxiant, which is intrinsically nontoxic. This seems to
be good news when thinking about using this gas as a
therapeutic agent. In addition, methane has favorable
distribution characteristics with its physical ability to
penetrate the membranes and diffuse into the organelles
[5]. Excessive oxidative stress is a major cause of some
diseases in which the mitochondrial respiratory chain is
a major source of devastating reactive oxygen species
(ROS), but antioxidants have limited therapeutic efficacy
which may be attributed to the impermeability of mem-
branes to them [12]. As methane can reach the nucleus
and mitochondria, the protection of nuclear DNA and
mitochondria suggests the protective effect of methane
on the oxidative stress-related diseases.
Furthermore, Pimentel et al. have hypothesized that
methane might confer an effect on membrane channels
because halothane, a hydrocarbon gas similar to methane,
has known demonstrable effects on G-proteins, mem-
brane or intracellular processing of the receptor signal
and acetylcholine activated ion channel kinetics [13-15].
In the study of Boros et al. [1], they hypothesized that
methane may accumulate transiently at cell membrane
interfaces, thereby change the physicochemical properties
or the in situ functionality of proteins embedded within
this environment, which may influence the function of
membrane bound enzymes, including xanthine oxidore-
ductase or those leading to ROS formation. Fink alsoproposed that whether mammalian cells contain an oxy-
genase that is capable of using methane as a substrate,
whether the biological effects of methane are caused by
the formation of small amounts of the reactive alcohol,
methanol, and/or changes in the redox milieu of the cell
due to changes in NAD(P)+/NAD(P)H ratio, and whether
there is a cellular “receptor” for methane are required to
be elucidated [16]. Thus, studies with elegant design are
required to confirm the exact molecular mechanism
underlying the protective effect of methane.
Issues in application of methane as a therapeutic gas
As above mentioned, the specific mechanism of the
therapeutic effect of methane is required to be further
elucidated in future studies. In addition, the therapeutic
effect of methane may be confirmed in other animal
models to elucidate whether the protective effect of
methane is species-specific.
The methane is abundant in natural gas and its se-
paration (production) is relatively easy. This is different
from xenon which is scarce in the atmosphere significantly
limiting the wide application of xenon as an inhaled
anesthetic. These advantageous characteristics make me-
thane very appealing as an inhaled gas for therapeu-
tic purposes. Since inhaled methane acts more rapidly,
methane inhalation may be suitable for defense against
acute oxidative stress. However, methane inhalation may
be impractical for daily application for disease prevention
due to its flammability and difficulty to transport. Thus,
normal saline rich in methane may be prepared as an
injection which may be portable, easily administered and
safe. This has been realized in application of H2 [17].
Of note, not all administered methane is degraded
in vivo and a majority of methane will be eliminated via
the lungs or the skin [18]. However, recent attention has
been paid to the potential of methane to contribute to
climatic change and global warming. Atmospheric me-
thane concentrations were stable until about 100 years
ago when concentrations began to rise. In 1992, it
was estimated methane would cause 15–17% of global
warming over the next 50 years [19] and methane has a
global warming potential of 25 compared to CO2 over a
100-year period (although accepted figures probably
represents an underestimate [20]. Thus, the recycle of
methane should be considered once it has been used as a
therapeutic gas.
In addition, whether administration of exogenous
methane may affect the production and excretion of
endogenous methane is another concern for methane
treatment. In the gastrointestinal diseases, methane has
been regarded as a “bad guy” [4] and whether adminis-
tration of methane increases the risk for these diseases
is unclear. If the administration of exogenous methane
affects the production of methane in the colon, the
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may cause imbalance among constituents of flatus is still
unclear. We assume that methane treatment for a long
time or with a high frequency might be detrimental, and
the influence of methane treatment for a short time on
intestinal flora or risk for gastrointestinal diseases is
needed to be further investigated.
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